Abstract 2037: Early identification of long-term survivors on tremelimumab plus durvalumab and chemotherapy in POSEIDON from pre-treatment CT images
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Kedar Patwardhan, Harish RaviPrakash, Qin Li, Ross Stewart
Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409632150
